MAXALT-MLT

Product NDC: 0006-3801
11-digit product format: 000063801
Labeler code: 0006
Product ID: 0006-3801_27f96f39-58fb-422e-ba80-be074e98fc07
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: rizatriptan benzoate
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: Merck Sharp & Dohme Corp.
Application: NDA020865
Marketing category: NDA
Marketing start: 1998-06-29
Marketing end: 0000-00-00
Substance: RIZATRIPTAN BENZOATE
Active strength: 10 mg/1
Pharmacologic classes: Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0006-3801		D	Discontinued by firm		2026-08-03
excluded package	package	0006-3801	0006-3801-18	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0006-3801-18	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0006-3801-18	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0006-3801-18	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0006-3801-18	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0006-3801-18	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0006-3801-18	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0006-3801-18	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0006-3801-18	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0006-3801-18	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0006-3801-18	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0006-3801-18	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0006-3801-18	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020865-001	MAXALT-MLT	RIZATRIPTAN BENZOATE	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29
N020865-002	MAXALT-MLT	RIZATRIPTAN BENZOATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N020865-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020865-001	MAXALT-MLT	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020865-001	MAXALT-MLT	EQ 5MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020865-001	MAXALT-MLT	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	TABLET, ORALLY DISINTEGRATING / ORAL		RLD	1998-06-29	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N020865-002	MAXALT-MLT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	AB	RLD, RS	1998-06-29	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020865-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020865-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020865-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020865-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020865-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020865-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020865-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020865-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020865-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020865-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020865-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020865-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020865-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020865-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020865-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020865-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020865-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020865-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020865-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020865-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020865-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020865-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020865-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020865-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020865-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020865-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020865-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020865-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020865-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020865-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020865-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020865-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020865-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020865-002	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020865-002	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020865-002	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020865-002	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020865-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020865-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020865-002	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f2791553-0b76-42f4-8d49-af3eda072bfb	Product name	1	20251117
707ffe6e-db52-42b0-9a65-a0c00213f04f	Product name	1	20231006
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
8b537454-32b8-7e64-1395-258682782d07	Product name	5	20170424
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0006-3801-01	EA - Each	0006-3801	f2e795c7-05e4-4ce9-bf98-5684084daac1	1	2012-07-24
0006-3801-12	EA - Each	0006-3801	349d83a8-c098-4f11-8dce-455eb7b497b4	1	2012-07-24
0006-3801-18	EA - Each	0006-3801	71e12342-334a-4d18-b8bd-bda45e9e60e1	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
rizatriptan benzoate	ACTIVE INGREDIENT	WR978S7QHH	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
rizatriptan	ACTIVE MOIETY	51086HBW8G	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
aspartame	INACTIVE INGREDIENT	Z0H242BBR1	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
gelatin	INACTIVE INGREDIENT	2G86QN327L	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
glycine	INACTIVE INGREDIENT	TE7660XO1C	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
mannitol	INACTIVE INGREDIENT	3OWL53L36A	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [MERCK SHARP & DOHME CORP.]	21
rizatriptan benzoate	ACTIVE INGREDIENT	WR978S7QHH	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
rizatriptan	ACTIVE MOIETY	51086HBW8G	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
aspartame	INACTIVE INGREDIENT	Z0H242BBR1	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
gelatin	INACTIVE INGREDIENT	2G86QN327L	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
glycine	INACTIVE INGREDIENT	TE7660XO1C	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
mannitol	INACTIVE INGREDIENT	3OWL53L36A	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MAXALT (RIZATRIPTAN BENZOATE) TABLET MAXALT-MLT (RIZATRIPTAN BENZOATE) TABLET, ORALLY DISINTEGRATING [PHYSICIANS TOTAL CARE, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MAXALT	RIZATRIPTAN BENZOATE	Organon LLC	007b4644-e0e7-4863-9ae3-fe09676b3f5f	2026-01-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020865 application number: NDA020865

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WR978S7QHH	RIZATRIPTAN BENZOATE	145202-66-0	RIZATRIPTAN BENZOATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
213322	Maxalt 10 MG Oral Tablet	PSN	3756d8e3-7e89-46c7-8723-6fea65363913	2
828537	Maxalt-MLT 10 MG Disintegrating Oral Tablet	PSN	3756d8e3-7e89-46c7-8723-6fea65363913	2
312837	rizatriptan benzoate 10 MG Disintegrating Oral Tablet	PSN	3756d8e3-7e89-46c7-8723-6fea65363913	2
314209	rizatriptan benzoate 10 MG Oral Tablet	PSN	3756d8e3-7e89-46c7-8723-6fea65363913	2
828537	rizatriptan 10 MG Disintegrating Oral Tablet [Maxalt]	SBD	3756d8e3-7e89-46c7-8723-6fea65363913	2
213322	rizatriptan 10 MG Oral Tablet [Maxalt]	SBD	3756d8e3-7e89-46c7-8723-6fea65363913	2
312837	rizatriptan 10 MG Disintegrating Oral Tablet	SCD	3756d8e3-7e89-46c7-8723-6fea65363913	2
314209	rizatriptan 10 MG Oral Tablet	SCD	3756d8e3-7e89-46c7-8723-6fea65363913	2
828537	Maxalt 10 MG Disintegrating Oral Tablet	SY	3756d8e3-7e89-46c7-8723-6fea65363913	2
213322	Maxalt 10 MG Oral Tablet	SY	3756d8e3-7e89-46c7-8723-6fea65363913	2
828537	Maxalt-MLT 10 MG Disintegrating Oral Tablet	SY	3756d8e3-7e89-46c7-8723-6fea65363913	2
312837	rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Disintegrating Oral Tablet	SY	3756d8e3-7e89-46c7-8723-6fea65363913	2
314209	rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Oral Tablet	SY	3756d8e3-7e89-46c7-8723-6fea65363913	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0006-3801-18	00006380118	6 CONTAINER in 1 CARTON (0006-3801-18) > 3 POUCH in 1 CONTAINER > 1 BLISTER PACK in 1 POUCH (0006-3801-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK	6 container	1998-06-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
MAXALT	Merck Sharp & Dohme Corp.	2021-10-31	HUMAN PRESCRIPTION DRUG LABEL	27
MAXALT	Physicians Total Care, Inc.	2012-03-14	HUMAN PRESCRIPTION DRUG LABEL	2